transcript of asx spotlight interview, page-26

@oslo - While I agree with your logic. I also disagree with the angle you are looking at this. For most of these projects, Anteo scientists won't have to lift a finger to investigate the potential of M&G being used in drug studies.

The drug companies will do all the necessary research for us. (initial testing, animal studies, Phase I,II,III trials). Anteo scientists chill out with a beer in hand and Anteo receives $$$$ and invaluable research data on their glue.

If the trials succeed and drugs are commercialised, Anteo will further receive $$$ from drug sales. We won't appreciated just how big Anteo can become until these large long term projects unfold.

@cronos - In answer to your questions:

"The use of M&G to bind drugs to polymer surfaces/nanoparticles is presently being investigated (is there any publically available info on this?)"
No. This project just started recently. Other projects, if they exist, are hidden behind non-disclosure agreements, much like 95% of Anteo's other projects.

"In your professional opinion a formulation of M&G is likely to be safe for use in humans"
My opinion is not professional, it's just an opinion. And these things cannot be predicted. In saying that, the raw glue definitely isn't safe, but in drug applications, the raw glue should never be exposed to the body anyway. So it probably has no harmful effects.


"Assuming for a moment I had the capability - might I use a M&G formulation to build a Cyborg in the future :)"
I personally hope one of the large companies GC mentioned in the talk show today is google(skynet). M&G is a strong double sided glue capable of binding biological tissue to non-biological surfaces. I can see where you are coming from and if you do have this capability, I think you should contact GC and start up some projects.


@Zebros - I don't see us receiving royalties from bioseparations, unless Anteo surprises us, and we find out that GE Healthcare is already heavily involved. I see Anteo making money from bioseparations through their own sales, which will earn much higher revenue than royalties ever will. We have already initiated sales in bioseparations, more coming later this year hopefully when 4-6 new products are released.